Medicine and Dentistry
Malignant Neoplasm
100%
COVID-19
46%
Immune Checkpoint Inhibitor
28%
Solid Malignant Neoplasm
23%
Pneumonia
21%
Oncology
18%
Symptomatic Treatment
16%
Cancer
16%
Supportive Care
16%
Thrombosis
15%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Infection
12%
Immune-Related Adverse Events
12%
Lung Cancer
11%
Cancer Pain
11%
Hospitalist
11%
Immunity
11%
Hospital Medicine
11%
Diseases
11%
Adverse Event
10%
Clinician
10%
Venous Thromboembolism
10%
Anticoagulation
8%
Cancer Cell
7%
Antibiotics
7%
Reactive Oxygen Species
7%
Lung
7%
Cancer Treatment
7%
Outpatient
7%
Odds Ratio
7%
Colitis
7%
Patient Advocate
7%
Internal Medicine
6%
Multivariate Analysis
6%
Overall Survival
6%
Retrospective Study
6%
Meta-Analysis
6%
Clinical Significance
6%
Immunotherapy
6%
Pandemic
6%
Thromboprophylaxis
5%
Prospective Cohort Study
5%
Infliximab
5%
Non Small Cell Lung Cancer
5%
Low Molecular Weight Heparin
5%
Diarrhea
5%
Neoplasm
5%
Pulmonary Edema
5%
Immunoglobulin
5%
Mandible Reconstruction
5%
Cannabidiol
5%
Cytokine Release Syndrome
5%
Pulmonary Embolism Response Team
5%
Leukemia Cell
5%
Mucositis
5%
Thrombotic Thrombocytopenic Purpura
5%
Tertiary Care
5%
B-Cell Chronic Lymphocytic Leukemia
5%
Microvascular Surgery
5%
Mesenteritis
5%
Catheter Thrombosis
5%
Isothiocyanic Acid
5%
Care Planning
5%
Cell Proliferation
5%
Enterocolitis
5%
Implant
5%
Drug Resistance
5%
Scoring System
5%
Bleeding
5%
Health Care Provider
5%
Medical Cannabis
5%
Cardiac Dysrhythmia
5%
Oxidative Stress
5%
Emergency Department
5%
Cardiovascular Disease
5%
Central Nervous System
5%
Hypoxia
5%
Systematic Review
5%
Cohort Analysis
5%
Cancer Rehabilitation
5%
Gastrostomy
5%
Manganese Superoxide Dismutase
5%
Randomized Controlled Trial
5%
Chemoradiotherapy
5%
Pulmonary Embolism
5%
Postcovid Syndrome
5%
Cell Therapy
5%
Fludarabine
5%
Prosthesis
5%
Bowel Obstruction
5%
Chimeric Antigen Receptor
5%
Digestive System Surgery
5%
Medical Oncology
5%
Gastroesophageal Junction
5%
Cancer Recurrence
5%
Fibrinolytic Therapy
5%
Ovarian Cancer
5%
Relebactam
5%
Care Pathway
5%
Febrile Neutropenia
5%
Keyphrases
In Cancer
26%
Cancer Patients
23%
Comprehensive Cancer Center
23%
Immune Checkpoint Inhibitors
20%
COVID-19
19%
Immune-related Adverse Events
16%
Care Program
15%
Goals of Care
15%
Readmission Rates
13%
Patients with Cancer
12%
Clinical Characteristics
12%
Solid Tumors
12%
Pneumonitis
11%
Propensity Score Analysis
10%
Narrative Review
10%
Unplanned Readmission
10%
Cancer-associated Thrombosis
10%
Confidence Interval
9%
30-day Readmission
8%
Risk Factors
8%
Readmission Risk
7%
Retrospective Analysis
7%
Readmission
7%
Medical Oncology
7%
Emergency Department
7%
Cancer Cells
7%
Chemotherapy
6%
Opioids
6%
Corticosteroids
6%
Clinical Significance
6%
Mortality Outcomes
6%
Checkpoint Inhibitors
6%
Colitis
6%
30-day Mortality
6%
Immune Checkpoint Inhibitor Therapy
6%
Cancer Hospital
6%
Healthcare Professionals
5%
Infliximab
5%
Program Implementation
5%
Advance Care Planning
5%
COVID-19 Pandemic
5%
Symptom Resolution
5%
Pain Management
5%
Checkpoint Inhibitor Pneumonitis
5%
Inpatient Care
5%
Odds Ratio
5%
Diarrhea
5%
MD Anderson Cancer Center
5%
Non-small Cell Lung Cancer Patients
5%
Oncology
5%
Medical Marijuana
5%
Survivorship
5%
Reactive Oxygen Species
5%
Co-creation
5%
Drug Interactions
5%
Excision
5%
Chronic Cancer Pain
5%
Chat-based
5%
Opioid Prescription
5%
Hospital Readmission Risk
5%
Risk Treatment
5%
Pulmonary Embolism Response Team
5%
Hospitalized COVID-19
5%
Transesophageal
5%
Slow Breathing
5%
Patient Care
5%
Serious Illness Conversation Guide
5%
Meditative Practices
5%
Emergency Severity Index
5%
Provider Perceptions
5%
Provider Beliefs
5%
Decompression
5%
OSW-1
5%
Risk Management
5%
Tertiary Care Hospital
5%
Clinical Guidance
5%
DNA Metabolism
5%
Preventability
5%
Multidisciplinary Approach
5%
Potentially Preventable
5%
Daily Care
5%
Breast Cancer Cells
5%
Risk Scoring System
5%
Transabdominal
5%
Sclerosing Mesenteritis
5%
Discharge Barriers
5%
Strategies to Overcome
5%
Mitochondrial Dysfunction
5%
Impact of Cancer
5%
Coronavirus Antibody
5%
Common Cold Coronaviruses
5%
Gastroenteritis
5%
Cytosolic Manganese Superoxide Dismutase (cMnSOD)
5%
Challenging Issues
5%
Attitude of Health Personnel
5%
Gastroesophageal Junction Cancer
5%
Hospital Costs
5%
Pulmonary Embolism
5%
Reporting Practices
5%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
5%